Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2023.03.30
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
2023.03.28
VOLUNTARY ANNOUNCEMENT ENTERING INTO LICENSE AND DISTRIBUTION AGREEMENT WITH OEP...
2023.03.17
VOLUNTARY ANNOUNCEMENT “ENOXAPARIN SODIUM INJECTION” OBTAINED ANDA APPROVAL FROM...
2023.03.15
DATE OF BOARD MEETING
2023.02.24
Overseas Regulatory Announcement
2023.02.24
Overseas Regulatory Announcement
2023.01.31
POSITIVE PROFIT ALERT ANNOUNCEMENT ON THE ESTIMATED INCREASE IN PROFIT FOR THE A...
2022.11.07
POLL RESULTS OF THE 2022 SECOND EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 4...
2022.10.28
2022 THIRD QUARTERLY RESULTS
2022.10.14
DATE OF BOARD MEETING
第一页
上一页
4
5
6
7
8
下一页
最后一页
